Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
Author Information
Author(s): de Melo Inês Guerra, Tavares Valéria, Savva-Bordalo Joana, Rei Mariana, Liz-Pimenta Joana, Pereira Deolinda, Medeiros Rui
Primary Institution: Portuguese Oncology Institute of Porto (IPO Porto)
Hypothesis
The impact of endothelial dysfunction-related genes and single-nucleotide polymorphisms (SNPs) on ovarian cancer-related venous thromboembolism (VTE) and patient prognosis was investigated.
Conclusion
Endothelial dysfunction markers are associated with ovarian cancer prognosis and VTE risk, suggesting their potential as prognostic factors.
Supporting Evidence
- Higher NOS3 expression was linked to lower VTE incidence.
- SELP upregulation was associated with shorter overall survival.
- Patients with SELP rs6136 T allele had lower progression-free survival.
Takeaway
This study looked at how certain genes related to blood vessel function affect the risk of blood clots and survival in ovarian cancer patients.
Methodology
A retrospective cohort study was conducted on 98 epithelial ovarian cancer patients, analyzing the association of endothelial dysfunction markers with VTE and prognosis.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the specific population sampled.
Limitations
The study's findings may be limited by the underrepresentation of certain genotypes and the need for larger cohorts for validation.
Participant Demographics
The mean age of participants was 63.2 years, with 80.6% being post-menopausal and 75.5% diagnosed at advanced cancer stages.
Statistical Information
P-Value
p = 0.013 for NOS3 and p = 0.048 for SELP
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website